Biological response to peri-implantitis treatment

Area of Science:

• Biomaterials Science
• Periodontology
• Immunology

Background:

• Peri-implantitis (PIP) is a prevalent complication following dental implant placement.
• Early diagnosis and effective treatment of PIP are crucial for implant survival.
• Identifying reliable biological markers in peri-implant crevicular fluid (PICF) can aid in assessing PIP status and treatment response.

Purpose of the Study:

• To investigate specific biological markers in PICF for diagnosing PIP.
• To evaluate changes in these markers following surgical and antimicrobial therapy for PIP.
• To correlate marker levels with clinical parameters of peri-implant health.

Main Methods:

• Clinical evaluation of 48 participants (24 healthy implants, 24 PIP).
• Collection of PICF samples at baseline and 3 months post-treatment.
• Quantification of interleukin-1β (IL-1β), matrix metalloproteinase-8 (MMP-8), and macrophage inflammatory protein-1α (MIP-1α) via immunoassay.

Main Results:

• Baseline PIP sites showed significantly higher IL-1β concentrations in PICF compared to healthy sites.
• Post-treatment, significant reductions in probing depth, bleeding on probing, and suppuration were observed.
• MMP-8 levels decreased significantly after treatment, indicating a healing response, while MIP-1α showed no significant difference.

Conclusions:

• Elevated IL-1β in PICF is a reliable indicator of active peri-implantitis.
• Decreased MMP-8 concentrations post-therapy suggest successful biological healing of peri-implant tissues.
• PICF analysis offers valuable insights into the inflammatory status and healing process of peri-implantitis.